Inventor · disambiguated record
Stéphanie Monnier
Also filed as: MONNIER STEPHANIE · MONNIER STEPHANIE M · MONNIER STÉPHANIE
10 granted patents·8 pending applications·98 citations·filing 2006–2014
89Inventor score
Technology areasA61P
Top patents by PatentIndex Score
18 records- 0194US8163904B2Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-BenzamideMANLEY PAUL W·Filed 2006·Granted Apr 24, 2012·32 cites·4 claims
- 0292US8389537B2Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideMANLEY PAUL W·Filed 2012·Granted Mar 5, 2013·17 cites·2 claims
- 0389US8415363B2Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideMANLEY PAUL W·Filed 2012·Granted Apr 9, 2013·15 cites·8 claims
- 0488US8580806B2Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideNOVARTIS AG·Filed 2013·Granted Nov 12, 2013·9 cites·2 claims
- 0588US8343984B2Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideNOVARTIS AG·Filed 2006·Granted Jan 1, 2013·11 cites·14 claims
- 0686US9163005B2Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideNOVARTIS AG·Filed 2013·Granted Oct 20, 2015·6 cites·1 claims
- 0786US8829015B2Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideNOVARTIS AG·Filed 2013·Granted Sep 9, 2014·7 cites·2 claims
- 0861US8198450B2Quinolinone derivatives and their pharmaceutical compositionsLOHSE OLIVIER·Filed 2007·Granted Jun 12, 2012·1 cites·16 claims
- 0961US2014343087A1Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamideMANLEY PAUL W·Filed 2014·Application pending·0 cites
- 1053US8119841B2Crystalline forms of aliskiren hemifumarateSTOWASSER FRANK·Filed 2007·Granted Feb 21, 2012·0 cites·23 claims
- 1145US8865897B2Crystal modifications-3-(1H-indol-3-yl)-4- [4-methyl-piperazin-1-yl)-quinazolin-4-yl] -pyrrole-2, 5-D ioneKARPINSKI PIOTR·Filed 2007·Granted Oct 21, 2014·0 cites·9 claims
- 1243US2009264461A1Polymorph of (R)-3- (2-Hydroxy-2, 2-Diphenyl -Acetoxy) -1- (Isoxazol-s-ylcarbamoyl-methyl)-1-Azoni A-Bicyclo-[2.2.2] Octane BromideMONNIER STEPHANIE·Filed 2007·Application pending·0 cites
- 1342US2009203777A1Organic compoundsDANAHAY HENRY LUKE·Filed 2006·Application pending·0 cites
- 1438US2010010039A1Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonistLOHSE OLIVIER·Filed 2007·Application pending·0 cites
- 1538US2012208882A1Organic CompoundsDANAHAY HENRY LUKE·Filed 2012·Application pending·0 cites
- 1636US2012316142A1Quinolinone derivatives and their pharmaceutical compositionsLOHSE OLIVIER·Filed 2012·Application pending·0 cites
- 1731US2011112121A1Pharmaceutical Compositions and Solid FormsBERGHAUSEN JOERG·Filed 2010·Application pending·0 cites
- 1830US2011275685A1Salt and polymorphs of a kinesin inhibitor compoundMUTZ MICHAEL·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stéphanie Monnier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →